We have advised Theras Group, an Italian company operating in the biomedical sector, on its acquisition of Pikdare's Consumer Health division, part of the MTD group, which operates under the Pic Solution brand, in a strategic transaction that expands the Group's scope of activity.
The transaction brings Pic Solution, a historic Italian brand with a long tradition in the medical devices sector and a consolidated position in consumer and professional channels, into the group. The brand boasts a widespread presence on the Italian market, with distribution in approximately 11,000 pharmacies, and is also active internationally in more than 80 countries worldwide, representing a platform of excellence for development in medical self-care.
Thanks to this acquisition, Theras Group is accelerating its growth path, expanding its market access channels and strengthening its presence across the entire care continuum. The transaction is part of a broader external innovation project aimed at developing new areas of activity and progressively expanding internationally.
The addition of Pic Solution also allows Theras Group to expand beyond its existing areas of expertise – diabetes, pain and obesity – to offer a multi-category range of consumer health products. This has led to the creation of Theras Consumer Health, a new division of the group that integrates and complements the hospital and specialist presence of Theras Lifetech.
Founded in 2011 and based in Salsomaggiore Terme, Theras Group develops and markets technological solutions and services dedicated to the management of chronic diseases, operating with an integrated model based on innovation, services supporting the therapeutic pathway and collaboration with the healthcare system, with the aim of improving the effectiveness of therapies and the quality of life for patients.
We acted as financial advisor to Theras Group, supporting management and shareholders throughout all stages of the transaction, both as M&A adviser and as debt adviser for the structuring of the financing. The transaction confirms Clearwater's role in supporting Italian industrial groups engaged in growth and strategic expansion in the healthcare sector.
The transaction was financed by a pool of banks consisting of Unicredit, as sole underwriter, Banco BPM, BBVA, Cassa Depositi e Prestiti, Credit Agricole Italia, Deutsche Bank and Intesa Sanpaolo.
